Tyra Biosciences, Inc. (TYRA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -32.57M | -23.62M | -22.38M | -23.68M | -25.46M | -19.59M | -17.9M | -10.26M | -22.03M | -13.53M | -17.14M | -9.62M | -9.85M | -11.98M | -12.21M | -17.17M | -8.93M | -9.03M | -5.58M | -4.46M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -27.94% | -20.59% | -25.04% | -130.84% | -15.57% | -44.77% | -4.39% | -6.69% | -123.7% | -12.95% | -40.39% | 43.99% | -10.33% | -32.7% | -118.93% | -284.85% | -90.79% | -256.84% | - | - |
| Net Income | -39.3M | -33.83M | -29.87M | -28.1M | -28.15M | -25.57M | -24.02M | -18.7M | -18.19M | -22.83M | -21.15M | -13.27M | -11.88M | -12.89M | -12.51M | -15.1M | -14.83M | -9.93M | -6.64M | -5.51M |
| Depreciation & Amortization | 138K | 132K | 131K | 140K | 143K | 144K | 127K | 126K | 122K | 102K | 82K | 86K | 83K | 82K | 82K | 68K | 64K | 50K | 41K | 27K |
| Stock-Based Compensation | 7.85M | 7.63M | 7.58M | 6.38M | 6.42M | 6.7M | 7.57M | 4.41M | 4.12M | 4.19M | 0 | 0 | 2.43M | 2.91M | 1.02M | 2.69M | 3.97M | 1.87M | 507K | 338K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 483K | 0 | 0 |
| Other Non-Cash Items | -65K | -126K | -419K | -708K | -866K | -1.18M | -1.6M | -1.87M | -1.23M | -1.25M | 4.38M | 2.53M | 0 | 0 | 1K | 0 | 2K | -483K | 3K | 0 |
| Working Capital Changes | -1.19M | 2.58M | 199K | -1.39M | -3.01M | 318K | 23K | 5.77M | -6.84M | 6.26M | -453K | 1.04M | -483K | -2.08M | -805K | -4.83M | 1.86M | -1.02M | 514K | 686K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 207K | 48K | 542K | 1.56M | 96K | 1.23M | 745K |
| Cash from Investing | -120.24M | 34.38M | -14.81M | 20.87M | 32.03M | 6.96M | 21.56M | -144.99M | 18.07M | -144.44M | -83K | -43K | -41K | -21K | -48K | -251K | -239K | -105K | -240K | -240K |
| Capital Expenditures | -88K | -57K | -39K | -31K | -14K | -6K | -52K | -470K | -136K | -603K | -83K | -43K | -41K | -21K | -48K | -251K | -239K | -105K | -256K | -240K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16K | 0 |
| Cash from Financing | 160.38M | 4.68M | 647K | 583K | 2.19M | 706K | 743K | 373K | 200.31M | 324K | 467K | 370K | 376K | 3K | 364K | 27K | 238K | -1.51M | 183.44M | -733K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K |
| Equity Issued (Net) | 160.38M | 4.68M | 647K | 583K | 2.19M | 706K | 743K | -251K | 199.83M | 324K | 467K | 370K | 376K | -629K | 364K | 27K | 238K | -1.51M | -23K | 3K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -251K | -169K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 624K | 484K | 0 | 0 | 0 | 0 | 632K | 0 | 0 | 0 | 0 | 183.46M | -731K |
| Net Change in Cash | 7.57M | 15.44M | -36.54M | -2.23M | 8.76M | -11.93M | 4.4M | -154.88M | 196.36M | -157.65M | -16.76M | -9.29M | -9.51M | -12M | -11.9M | -17.39M | -8.93M | -10.64M | 177.62M | -5.43M |
| Free Cash Flow | -32.66M | -23.68M | -22.42M | -23.71M | -25.47M | -19.6M | -17.95M | -10.73M | -22.16M | -14.13M | -17.23M | -9.66M | -9.89M | -12M | -12.26M | -17.42M | -9.16M | -9.13M | -5.83M | -4.7M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -28.22% | -20.85% | -24.9% | -121.02% | -14.93% | -38.63% | -4.19% | -11.08% | -124.15% | -17.78% | -40.52% | 44.55% | -7.9% | -31.4% | -110.15% | -270.54% | -93.41% | -251.68% | - | - |
| FCF per Share | -0.53 | -0.40 | -0.38 | -0.40 | -0.43 | -0.33 | -0.30 | -0.18 | -0.42 | -0.33 | -0.40 | -0.23 | -0.23 | -0.28 | -0.29 | -0.42 | -0.22 | -0.22 | -0.64 | -0.13 |
| FCF Conversion (FCF/Net Income) | 0.83x | 0.70x | 0.75x | 0.84x | 0.90x | 0.77x | 0.75x | 0.55x | 1.21x | 0.59x | 0.81x | 0.72x | 0.83x | 0.93x | 0.98x | 1.14x | 0.60x | 0.91x | 0.84x | 0.81x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |